Procter & Gamble (NYSE:PG – Get Free Report) had its price target dropped by analysts at BNP Paribas Exane from $172.00 to $164.00 in a research report issued to clients and investors on Friday,MarketScreener reports. The firm presently has an “outperform” rating on the stock. BNP Paribas Exane’s price target would suggest a potential upside of 13.46% from the stock’s previous close.
Several other research analysts have also issued reports on PG. Barclays set a $155.00 price target on Procter & Gamble in a research report on Friday. Cowen reissued a “buy” rating on shares of Procter & Gamble in a research note on Thursday, January 8th. Bank of America lowered their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Raymond James Financial reduced their price target on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research report on Monday, October 20th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, December 29th. Fifteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $168.36.
Check Out Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Trading Down 0.1%
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The company had revenue of $22.39 billion for the quarter, compared to the consensus estimate of $22.23 billion. During the same period in the prior year, the company posted $1.93 EPS. The company’s revenue was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Equities research analysts forecast that Procter & Gamble will post 6.91 EPS for the current fiscal year.
Insider Buying and Selling
In related news, CAO Matthew W. Janzaruk sold 725 shares of the business’s stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total transaction of $108,438.25. Following the transaction, the chief accounting officer owned 979 shares in the company, valued at $146,429.03. The trade was a 42.55% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.20% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in the company. Howard Capital Management Group LLC boosted its stake in shares of Procter & Gamble by 1.4% in the 4th quarter. Howard Capital Management Group LLC now owns 8,357 shares of the company’s stock worth $1,198,000 after buying an additional 117 shares during the last quarter. Sharp Wealth Advisory LLC bought a new stake in Procter & Gamble during the fourth quarter worth $349,000. Balboa Wealth Partners boosted its position in Procter & Gamble by 14.7% in the fourth quarter. Balboa Wealth Partners now owns 7,025 shares of the company’s stock worth $1,007,000 after purchasing an additional 901 shares during the last quarter. Heck Capital Advisors LLC grew its stake in Procter & Gamble by 6.7% in the 4th quarter. Heck Capital Advisors LLC now owns 24,972 shares of the company’s stock valued at $3,579,000 after purchasing an additional 1,561 shares during the period. Finally, Hopwood Financial Services Inc. increased its position in shares of Procter & Gamble by 2.5% during the 4th quarter. Hopwood Financial Services Inc. now owns 5,880 shares of the company’s stock valued at $843,000 after purchasing an additional 144 shares during the last quarter. 65.77% of the stock is owned by institutional investors.
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: P&G announced a dividend increase that pushed shares higher after the news; investors often view dividend raises as a sign of cash-flow confidence. Procter & Gamble (NYSE:PG) Shares Up 1.4% Following Dividend Announcement
- Positive Sentiment: UBS reiterated a Buy rating on PG, which can lend support to the stock by reinforcing institutional conviction. UBS Sticks to Their Buy Rating for Procter & Gamble (PG)
- Positive Sentiment: Dividend-focused coverage included P&G in a roundup of high-yield and dividend-resilient names, reinforcing interest from income-oriented investors. Dividend roundup: Goldman Sachs, Procter & Gamble, Costco, Caterpillar, and more
- Neutral Sentiment: Zacks published an in-depth preview of Q2 metrics (beyond EPS/revenue), offering models and expectations investors should watch when the quarter posts—useful for positioning but not an immediate catalyst. Insights Into P&G (PG) Q2: Wall Street Projections for Key Metrics
- Neutral Sentiment: The options market shows unusual activity that some interpret as signaling bigger moves ahead; this is mixed info—could indicate hedging or directional bets. Is the Options Market Predicting a Spike in Procter & Gamble Stock?
- Neutral Sentiment: P&G is scheduled to report earnings soon (projected posting), keeping the stock sensitive to the quarter’s top-line and margin details. Procter & Gamble (PG) Projected to Post Earnings on Thursday
- Neutral Sentiment: A comparative profile vs. smaller peer Synergy CHC was published; not directly market-moving for PG but helpful context for sector/peer analysis. Head to Head Comparison: Procter & Gamble (NYSE:PG) vs. Synergy CHC (NASDAQ:SNYR)
- Neutral Sentiment: P&G appears on lists of dividend-paying Dow stocks (Dogs of the Dow coverage), which can attract income-focused flows over time but is not an immediate catalyst. The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8%
- Neutral Sentiment: Media noted that CEO stock incentives could meaningfully increase his compensation—this aligns management with shareholders but may raise questions about dilution/compensation structure for some investors. Procter & Gamble CEO could see major wealth boost from stock incentives
- Negative Sentiment: Zacks’ earnings preview warned Q2 EPS may decline and suggested P&G may lack the mix for an earnings beat—this raises short-term downside risk if results disappoint. Earnings Preview: Procter & Gamble (PG) Q2 Earnings Expected to Decline
- Negative Sentiment: Large put buying was reported (76,923 puts), a roughly 190% jump vs. typical volume—this is a bearish options signal that could amplify volatility or signal hedging against a near-term drop. Is the Options Market Predicting a Spike in Procter & Gamble Stock?
- Negative Sentiment: A report noted an insider (Rep. Gilbert Ray Cisneros, Jr.) sold shares; insider selling can be perceived negatively even if non-material. Procter & Gamble (NYSE:PG) Stock Unloaded Rep. Gilbert Ray Cisneros, Jr.
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- Market Legend Reveals #1 Stock for 2026
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
